FILTRI
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05249894
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT03955848
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04867928
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04763928
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04454580
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04166929
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT03058588
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04460963
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Non Disponibile
As Dell'Alto Adige, Ospedale Centrale Di Bolzano - Ematologia E Centro Trapianto Midollo Osseo, Bolzano, Italy
U.O. Oncoematologia IOV, Castelfranco Veneto, Italy
Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03686345
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
- Stato: Non ancora in arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04709458
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
University Hospital Centre Zagreb, Zagreb, Croatia
Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04342962
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
Irccs Aou San Martino - Genova - Uo Clinica Ematologica, Genova, Italy
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora, Milano, Italy
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03789981
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
AO Spedali Civili di Brescia, Brescia, BS, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
IRCCS Casa sollievo sofferenza, San Giovanni Rotondo, Foggia, Italy
IRCCS AOU S. Martino Genova, Genova, GE, Italy
Ospedale G. Da Saliceto, Piacenza, PC, Italy
Irccs Crob, Rionero in Vulture, PZ, Italy
Osp. S. Maria delle Croci, Ravenna, RA, Italy
Ospedale degli Infermi, Rimini, RN, Italy
AOU Senese, Siena, SI, Italy
Università di Torino, Orbassano, TO, Italy
AO Ordine Mauriziano di Torino, Torino, TO, Italy
Azienda ULSS2 Marca Trevigiana, Treviso, TV, Italy
AOU Maggiore della Carità, Novara, Italy
AOU di Udine, Udine, Italy
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03410407
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, Bari, Italy
Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo, Cagliari, Italy
Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora, Milano, Italy
Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy
Aou Maggiore Della Carita' Di Novara - Scdu Ematologia, Novara, Italy
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
Asl Di Piacenza, Ospedale "Guglielmo Da Saliceto" - Ematologia E Centro Trapianti, Piacenza, Italy
Aou Policlinico Tor Vergata - Roma - Uoc Trapianto Cellule Staminali, Roma, Italy
Dipartimento di Biotecnologie Cellulari ed Ematologia, "Sapienza", Università di Roma, Roma, Italy
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, Roma, Italy
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy
Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy
Long-term Outcomes for Acute Myeloid Leukemia Patients
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03755856
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI, Ancona, Italy
U.O. Ematologia con trapianto - Azienda Ospedaliero-Universitaria Policlinico di Bari, Bari, Italy
UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli", Barletta, Italy
Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy
ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy
Divisione clinicizzata di Ematologia - Dipartimento di Scienze Mediche - Osp. Ferrarotto, Catania, Italy
Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Cona, Italy
Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, Foggia, Italy
IRCCS_AOU San Martino-IST.Clinica Ematologica, Genova, Italy
Milano Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy
Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Napoli, Italy
UOC di Ematologia-Centro Emofilia e Trombosi - Ospedale Ascalesi - ASL Napoli 1, Napoli, Italy
S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy
Orbassano Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2, Orbassano, Italy
Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy
U.O. di Ematologia con trapianto - A.U. Policlinico "Paolo Giaccone", Palermo, Italy
U.O. Ematologia e CTMO- AOU di Parma, Parma, Italy
Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto, Piacenza, Italy
Ematologia - Ospedale San Carlo, Potenza, Italy
Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, Reggio Emilia, Italy
Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia, Roma, Italy
Divisione di Ematologia - Ospedale S.Eugenio, Roma, Italy
Ematologia Policlinico - Università degli Studi di Roma Tor Vergata (PTV), Roma, Italy
Istituto di Semeiotica Medica - Ematologia - Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy
Roma Divisione Ematologia - Università Campus Bio-Medico, Roma, Italy
Università degli Studi "Sapienza" - Dip Medicina di Precisione e Ricerca Traslazionale UOC Ematologia, Roma, Italy
U.O. di Ematologia - Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
Ematologia - AOU Sassari, Sassari, Italy
Torino Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy
UZ Gasthuisberg, Leuven, Belgium
CHR Citadelle-CHU, Liège, Belgium
University of Liège, Liège, Belgium
KBC Rijeka, Rijeka, Croatia
University Hospital Centre Zagreb, Zagreb, Croatia
Les Hôpitaux Universitaires de Strasbourg, Lyon, France
University Clinic of Hematology-Skopje, Skopje, North Macedonia
University hospital Bratislava, Bratislava, Slovakia
UKC Ljubljana, Ljubljana, Slovenia
Ankara University School Of Medicine Cebeci Campus Adult Hematology Department and BMT Unit, Ankara, Turkey
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04102020
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 213944, Ancona, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 213948, Bologna, Italy
ASST Spedali civili di Brescia /ID# 214580, Brescia, Italy
A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 214802, Catania, Italy
Ospedale Policlinico San Martino /ID# 240017, Genova, Italy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS /ID# 240018, Meldola, Italy
ASST Grande Ospedale Metropolitano Niguarda /ID# 213946, Milano, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 214826, Milan, Italy
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli /ID# 213947, Napoli, Italy
Azienda Ospedaliera Universitaria Federico II /ID# 214278, Napoli, Italy
Grande Ospedale Metropolitano Bianchi Melacrino Morelli /ID# 240016, Reggio Calabria, Italy
Ospedale S.Eugenio /ID# 214277, Rome, Italy
Azienda Sanitaria Universitaria Giuliano Isontina /ID# 240010, Trieste, Italy
A.O.U. Citta della Salute e della Scienza di Torino /ID# 214505, Turin, Italy
ASST Sette Laghi /ID# 240019, Varese, Italy
Mitchell Cancer Institute /ID# 216443, Mobile, Alabama, United States
Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156, Fountain Valley, California, United States
University of California, Los Angeles /ID# 219149, Los Angeles, California, United States
Colorado Blood Cancer Institute /ID# 214280, Denver, Colorado, United States
Baptist MD Anderson Cancer Center - Jacksonville /ID# 239360, Jacksonville, Florida, United States
St. Alphonsus Regional Medical /ID# 216424, Boise, Idaho, United States
Rush University Medical Center /ID# 218815, Chicago, Illinois, United States
NorthShore University HealthSystem Research Institute /ID# 240029, Evanston, Illinois, United States
Indiana Univ School Medicine /ID# 216447, Indianapolis, Indiana, United States
University of Kentucky Markey Cancer Center /ID# 215048, Lexington, Kentucky, United States
Norton Cancer Institute /ID# 216401, Louisville, Kentucky, United States
Tulane Medical Center - New Orleans /ID# 218166, New Orleans, Louisiana, United States
Ochsner Clinic Foundation-New Orleans /ID# 214583, New Orleans, Louisiana, United States
Tufts Medical Center /ID# 216110, Boston, Massachusetts, United States
Massachusetts General Hospital /ID# 217307, Boston, Massachusetts, United States
UMass Chan Medical School /ID# 218163, Worcester, Massachusetts, United States
University of Mississippi Medical Center /ID# 216475, Jackson, Mississippi, United States
Saint Louis University Cancer Center /ID# 218164, Saint Louis, Missouri, United States
Oncology Hematology Associates (OHA) - Springfield /ID# 216351, Springfield, Missouri, United States
The John Theurer Cancer /ID# 215191, Hackensack, New Jersey, United States
Atlantic Health System /ID# 239323, Morristown, New Jersey, United States
Rutgers Cancer Institute of New Jersey /ID# 239708, New Brunswick, New Jersey, United States
Weill Cornell Medical College /ID# 214847, New York, New York, United States
Cleveland Clinic Main Campus /ID# 239339, Cleveland, Ohio, United States
The Ohio State University - The James /ID# 215612, Columbus, Ohio, United States
Providence Portland Medical Ct /ID# 216231, Portland, Oregon, United States
Fox Chase Cancer Center /ID# 239372, Philadelphia, Pennsylvania, United States
UPMC Hillman Cancer Ctr /ID# 214051, Pittsburgh, Pennsylvania, United States
Prisma Health Cancer Institute-Faris Road /ID# 216066, Greenville, South Carolina, United States
St Francis Cancer Center /ID# 216115, Greenville, South Carolina, United States
Gibbs Cancer Center & Research /ID# 216192, Spartanburg, South Carolina, United States
Tennessee Oncology-Nashville Centennial /ID# 218757, Nashville, Tennessee, United States
Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 214584, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center /ID# 225201, Houston, Texas, United States
Intermountain Healthcare /ID# 217956, Salt Lake City, Utah, United States
St George Hospital /ID# 215416, Kogarah, New South Wales, Australia
Liverpool Hospital /ID# 215415, Liverpool, New South Wales, Australia
Shoalhaven District Memorial Hospital /ID# 221973, Nowra, New South Wales, Australia
Wollongong Hospital /ID# 216071, Wollongong, New South Wales, Australia
Gold coast University Hospital /ID# 214650, SouthPort, Queensland, Australia
Toowoomba Hospital /ID# 217922, Toowoomba, Queensland, Australia
Princess Alexandra Hospital /ID# 238753, Woolloongabba, Queensland, Australia
Royal Adelaide Hospital /ID# 238754, Adelaide, South Australia, Australia
Box Hill Hospital /ID# 217622, Box Hill, Victoria, Australia
Barwon Health /ID# 217921, Geelong, Victoria, Australia
Perth Blood Institute Ltd /ID# 217531, Nedlands, Western Australia, Australia
Universitaetsklinikum St. Poelten /ID# 239225, Sankt Poelten, Niederoesterreich, Austria
Ordensklinikum Linz GmbH Elisabethinen /ID# 239434, Linz, Oberoesterreich, Austria
Klinikum Wels-Grieskirchen GmbH /ID# 239195, Wels, Oberoesterreich, Austria
Medizinische Universitaet Wien /ID# 240499, Vienna, Wien, Austria
Hanusch Krankenhaus /ID# 239445, Wien, Austria
Hospital São Rafael /ID# 215233, Salvador, Bahia, Brazil
Hospital de Clinicas de Porto Alegre /ID# 215044, Porto Alegre, Rio Grande Do Sul, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 215234, Sao Jose Do Rio Preto, Sao Paulo, Brazil
Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA) /ID# 215171, Rio de Janeiro, Brazil
Tom Baker Cancer Centre /ID# 214625, Calgary, Alberta, Canada
University of Alberta Hospital - Division of Hematology /ID# 215656, Edmonton, Alberta, Canada
QEII - Health Sciences Centre /ID# 239456, Halifax, Nova Scotia, Canada
Juravinski Cancer Centre /ID# 214623, Hamilton, Ontario, Canada
London Health Sciences Center /ID# 216055, London, Ontario, Canada
Ottawa Hospital Research Institute /ID# 214627, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre /ID# 214624, Toronto, Ontario, Canada
McGill University Health Center Research Institute /ID# 215984, Montreal, Quebec, Canada
Peking University People's Hospital /ID# 216331, Beijing, Beijing, China
Peking Union Medical College Hospital /ID# 216454, Beijing, Beijing, China
Chinese PLA General Hospital /ID# 216286, Beijing, Beijing, China
Fujian Medical University Union Hospital /ID# 215561, Fuzhou, Fujian, China
Guangdong Provincial People's Hospital /ID# 216284, Guangzhou, Guangdong, China
Nanfang Hospital of Southern Medical University /ID# 215565, Guangzhou, Guangdong, China
Henan Cancer Hospital /ID# 215566, Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 218046, Wuhan, Hubei, China
The First Hospital of Jilin University /ID# 215560, Changchun, Jilin, China
The First Hospital of China Medical University /ID# 216285, Shenyang, Liaoning, China
Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 216283, Xi'an, Shaanxi, China
Shanghai Tongji Hospital /ID# 218800, Shanghai, Shanghai, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 215558, Tianjin, Tianjin, China
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215564, Hangzhou, Zhejiang, China
Beijing Friendship Hospital /ID# 216455, Beijing, China
Peking University International Hospital /ID# 217439, Beijing, China
West China Hospital, Sichuan University /ID# 216606, Chengdu, China
Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 216456, Wuhan, China
Fakultni Nemocnice Brno /ID# 214807, Brno, Czechia
Fakultni nemocnice Hradec Kralove /ID# 246168, Hradec Kralove, Czechia
Fakultni nemocnice Ostrava /ID# 214809, Ostrava, Czechia
Ustav hematologie a krevni transfuze /ID# 215137, Praha, Czechia
CHU de Nice - Hôpital Archet 1 /ID# 217368, Nice, Alpes-Maritimes, France
HCL - Hôpital Lyon Sud /ID# 239904, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France
CHU de Rennes - PONTCHAILLOU /ID# 239906, Rennes, Bretagne, France
CHU Bordeaux - Hopital Haut Leveque /ID# 215150, Pessac CEDEX, Gironde, France
CHRU Lille - Hopital Claude Huriez /ID# 217474, Lille, Hauts-de-France, France
CHU Montpellier - Hôpital Saint Eloi /ID# 239907, Montpellier Cedex 5, Herault, France
Hopital Avicenne - APHP /ID# 215152, Bobigny, Ile-de-France, France
CHRU Tours - Hopital Bretonneau /ID# 216186, Tours CEDEX 9, Indre-et-Loire, France
CHRU Nancy - Hôpitaux de Brabois /ID# 239903, Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
CHU de Nantes, Hotel Dieu -HME /ID# 217367, Nantes, Pays-de-la-Loire, France
Centre Hospitalier de la Cote /ID# 216185, Bayonne, Pyrenees-Atlantiques, France
Centre Hospitalier du Mans /ID# 215148, Le Mans CEDEX 9, Sarthe, France
Institut Gustave Roussy /ID# 215158, Villejuif Cedex, Val-de-Marne, France
Chu Angers /Id# 215151, Angers, France
Hopital Henri Mondor /ID# 215159, Creteil, France
Centre Hospitalier de Versailles André Mignot /ID# 215157, Le Chesnay, France
IUCT Oncopole /ID# 239905, Toulouse Cedex 9, France
Universitatsklinikum Mannheim /ID# 239762, Mannheim, Baden-Wuerttemberg, Germany
Universitaetsklinikum Koeln /ID# 239763, Köln, Nordrhein-Westfalen, Germany
Universitaetsklinikum Leipzig /ID# 214440, Leipzig, Sachsen, Germany
Universitaetsklinikum Jena /ID# 239766, Jena, Thueringen, Germany
Klinikum Chemnitz gGmbH /ID# 216073, Chemnitz, Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 240983, Dresden, Germany
Universitaetsklinikum Essen /ID# 239764, Essen, Germany
Universitaetsklinikum Halle (Saale) /ID# 221109, Halle (Saale), Germany
Staedtisches Krankenhaus Kiel /ID# 239761, Kiel, Germany
Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 215173, Luebeck, Germany
Universitaetsklinikum Giessen und Marburg /ID# 214734, Marburg, Germany
Rotkreuzkliniken Munchen /ID# 239767, Munich, Germany
Krankenhaus Barmherzige Brueder Regensburg /ID# 215170, Regensburg, Germany
Universitaetsmedizin Rostock /ID# 239765, Rostock, Germany
General Hospital of Athens Laiko /ID# 213869, Athens, Attiki, Greece
University General Hospital Attikon /ID# 214298, Athens, Attiki, Greece
University General Hospital of Heraklion PA.G.N.I /ID# 214075, Heraklion, Kriti, Greece
General University Hospital of Alexandroupolis /ID# 213870, Alexandroupolis, Greece
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 213872, Athens, Greece
University General Hospital of Patras /ID# 213871, RION Patras Achaia, Greece
Debreceni Egyetem Klinikai Kozpont /ID# 214422, Debrecen, Hajdu-Bihar, Hungary
Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz Josa Andras Okta /ID# 214425, Nyíregyháza, Nyiregyhaza, Hungary
Somogy Megyei Kaposi Mor Oktato Korhaz /ID# 214426, Kaposvár, Somogy, Hungary
Markusovszky Egyetemi Oktatokorhaz /ID# 215644, Szombathely, Vas, Hungary
Semmelweis Egyetem /ID# 214423, Budapest, Hungary
Soroka University Medical Center /ID# 240856, Be'er Sheva, HaDarom, Israel
Tel Aviv Sourasky Medical Center /ID# 239698, Tel Aviv-Yafo, Tel-Aviv, Israel
The Lady Davis Carmel Medical Center /ID# 239706, Haifa, Israel
Shaare Zedek Medical Center /ID# 239699, Jerusalem, Israel
Hadassah Medical Center-Hebrew University /ID# 239700, Jerusalem, Israel
Rabin Medical Center /ID# 239696, Petakh Tikva, Israel
Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital /ID# 215680, Nagoya-shi, Aichi, Japan
Aichi Cancer Center Hospital /ID# 215284, Nagoya-shi, Aichi, Japan
University of Fukui Hospital /ID# 215283, Yoshida-gun, Fukui, Japan
National Hospital Organization Kyushu Cancer Center /ID# 214841, Fukuoka-shi, Fukuoka, Japan
Kyushu University Hospital /ID# 215286, Fukuoka-shi, Fukuoka, Japan
Hokkaido University Hospital /ID# 215938, Sapporo-shi, Hokkaido, Japan
National Hospital Organization Mito Medical Center /ID# 214699, Higashi Ibaraki-gun, Ibaraki, Japan
Hitachi General Hospital /ID# 214707, Hitachi-shi, Ibaraki, Japan
Tohoku University Hospital /ID# 214669, Sendai-shi, Miyagi, Japan
Nagasaki University Hospital /ID# 214916, Nagasaki-shi, Nagasaki, Japan
Okayama University Hospital /ID# 214840, Okayama-shi, Okayama, Japan
Osaka Metropolitan University Hospital /ID# 215225, Osaka-shi, Osaka, Japan
Kindai University Hospital /ID# 214915, Osakasayama-shi, Osaka, Japan
Saitama Medical University International Medical Center /ID# 214823, Hidaka-shi, Saitama, Japan
Jichi Medical University Saitama Medical Center /ID# 219148, Saitama-shi, Saitama, Japan
Jichi Medical University Hospital /ID# 216812, Shimotsuke-shi, Tochigi, Japan
NTT Medical Center Tokyo /ID# 214959, Shinagawa-ku, Tokyo, Japan
Yamagata University Hospital /ID# 214698, Yamagata-shi, Yamagata, Japan
Seoul National University Bundang Hospital /ID# 215549, Seongnam, Gyeonggido, Korea, Republic of
Pusan National University Hospital /ID# 213941, Busan, Korea, Republic of
Seoul National University Hospital /ID# 213943, Seoul, Korea, Republic of
Samsung Medical Center /ID# 213940, Seoul, Korea, Republic of
Szpital Wojewodzki w Opolu sp. z o.o. /ID# 241924, Opole, Dolnoslaskie, Poland
Szpital Uniwersytecki nr 2 im. dr. Jana Biziela /ID# 239481, Bydgoszcz, Kujawsko-pomorskie, Poland
MICS Centrum Medyczne Torun /ID# 241269, Torun, Kujawsko-pomorskie, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopern /ID# 239484, Lodz, Lodzkie, Poland
SP ZOZ Szpital Uniwersytecki w Krakowie /ID# 244246, Krakow, Malopolskie, Poland
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka /ID# 239555, Slupsk, Pomorskie, Poland
Szpital Kliniczny im. Heliodora Swiecickiego Uniwersytetu Medycznego im. Karola /ID# 239483, Poznań, Poland
IPO Lisboa FG, EPE /ID# 240972, Lisboa, Portugal
Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 241131, Lisboa, Portugal
IPO Porto FG, EPE /ID# 240970, Porto, Portugal
Centro Hospitalar Universitario de Sao Joao, EPE /ID# 241025, Porto, Portugal
Pan American Center for Oncology Trials, LLC /ID# 214953, Rio Piedras, Puerto Rico
Nizhny Novgorod Regional Clinical Hospital named N.A. Semashko /ID# 214309, Nizhniy Novgorod, Nizhegorodskaya Oblast, Russian Federation
Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 215393, St. Petersburg, Sankt-Peterburg, Russian Federation
Moscow Cancer Research Institute n.a. P. A. Herzen /ID# 214312, Moscow, Russian Federation
City Clinical Hospital #40 of the Moscow City Health Department /ID# 215223, Moscow, Russian Federation
Clinic of Immunopathology, SRIFCI /ID# 217937, Novosibirsk, Russian Federation
Almazov National Medical Research Centre /ID# 214306, Sankt-Peterburg, Russian Federation
Regional Clinical Hospital of Yaroslavl /ID# 214318, Yaroslavl, Russian Federation
Instituto Catalan de Oncologia (ICO) Badalona /ID# 240152, Badalona, Barcelona, Spain
Instituto Catalan de Oncologia (ICO) L'Hospitalet /ID# 214715, Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Dr. Negrin /ID# 239887, Las Palmas de Gran Canaria, Las Palmas, Spain
CLINICA UNIVERSIDAD DE NAVARRA-Pamplona /ID# 238889, Pamplona, Navarra, Spain
Hospital Universitario de Navarra /ID# 214788, Pamplona, Navarra, Spain
Complejo Hospitalario Universitario Ourense /ID# 214787, Orense, Ourense, Spain
Hospital Universitario A Coruna - CHUAC /ID# 238883, A Coruna, Spain
Hospital Clinic de Barcelona /ID# 238884, Barcelona, Spain
Hospital Santa Creu i Sant Pau /ID# 214714, Barcelona, Spain
Hospital Universitario Reina Sofia /ID# 214786, Cordoba, Spain
Hospital General Universitario Gregorio Maranon /ID# 238885, Madrid, Spain
CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 242388, Madrid, Spain
Hospital Universitario Infanta Leonor /ID# 214843, Madrid, Spain
MD Anderson Madrid /ID# 214477, Madrid, Spain
Hospital Universitario Ramon y Cajal /ID# 214684, Madrid, Spain
Hospital Universitario Fundacion Jimenez Diaz /ID# 214933, Madrid, Spain
Hospital Universitario 12 de Octubre /ID# 214789, Madrid, Spain
Hospital Universitario Virgen de la Victoria /ID# 214713, Malaga, Spain
Hospital Universitario Virgen del Rocio /ID# 238887, Sevilla, Spain
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 213953, Kaohsiung, Taiwan
China Medical University Hospital /ID# 213952, Taichung City, Taiwan
National Taiwan University Hospital /ID# 213939, Taipei City, Taiwan
Linkou Chang Gung Memorial Ho /ID# 213951, Taoyuan City, Taiwan
Cukurova Universitesi Tip Fakultesi /ID# 239920, Saricam Adana, Adana, Turkey
Erciyes University Medical Fac /ID# 214240, Melikgazi, Kayseri, Turkey
Gulhane Askeri Tip Academy /ID# 214242, Ankara, Turkey
Hacettepe University Medical Faculty /ID# 239857, Ankara, Turkey
Ankara Univ Medical Faculty /ID# 214239, Ankara, Turkey
Ankara City Hospital /ID# 239859, Ankara, Turkey
Adnan Menderes University /ID# 239856, Aydin, Turkey
Osmangazi Universitesi Tip Fak /ID# 239281, Eskisehir, Turkey
Gaziantep Universitesi Med /ID# 239855, Gaziantep, Turkey
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 215525, Istanbul, Turkey
Bagcilar Medipol Mega Universite Hastanesi /ID# 239280, Istanbul, Turkey
Prof. Dr. Suleyman Yalcın Sehir Hastanesi /ID# 239282, Istanbul, Turkey
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 244901, Istanbul, Turkey
Dokuz Eylul University Medical Faculty /ID# 239276, Izmir, Turkey
Ondokuz mayis University Facul /ID# 239858, Samsun, Turkey
Karadeniz University /ID# 214241, Trabzon, Turkey
University Hospitals Bristol /ID# 215911, Bristol, Bristol, City Of, United Kingdom
Leicester Royal Infirmary /ID# 215924, Leicester, England, United Kingdom
Barts Health NHS Trust /ID# 215909, London, London, City Of, United Kingdom
Guy's and St Thomas' NHS Foundation Trust /ID# 215908, London, London, City Of, United Kingdom
Cardiff & Vale University Health Board /ID# 215906, Cardiff, Wales, United Kingdom
Belfast Health and Social Care Trust /ID# 215923, Belfast, United Kingdom
University Hospitals Birmingham NHS Foundation Trust /ID# 215910, Birmingham, United Kingdom
Leeds Teaching Hospitals NHS Trust /ID# 215922, Leeds, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust /ID# 239332, Liverpool, United Kingdom
University College London Hospitals NHS Foundation Trust /ID# 215921, London, United Kingdom
King's College Hospital NHS Foundation Trusts /ID# 239326, London, United Kingdom
Portsmouth Hospitals University NHS Trust /ID# 239324, Portsmouth, United Kingdom
St George's University Hospitals NHS Foundation Trust /ID# 239328, Tooting, United Kingdom
Torbay and South Devon Nhs Foundation Trust /Id# 239331, Torquay, United Kingdom
SEL24/MEN1703 in Patients With Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03008187
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Istituto Clinico Humanitas, Milano, Italy
ASST Monza - Ospedale San Gerardo, Monza, Italy
Northside Hospital, Atlanta, Georgia, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Stony Brook University Cancer Center, Stony Brook, New York, United States
Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
Allegheny Health Network, West Penn Hospital, Pittsburgh, Pennsylvania, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Institute of Haematology and Blood Transfusion, Warsaw, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Oddzial Hematologii z Pododdzialem Chemioterapi, Łódź, Poland
Institut Català d'Oncologia, Badalona, Spain
Hospital 12 de Octubre, Madrid, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) With Newly Diagnosed AML Eligible for Allo-SCT
- Stato: Non ancora in arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04476199
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
UO Ematologia e TMO - Ospedale C. Panico, Tricase, Lecce, Italy
Clinica di Ematologia. AOU Ospedali Riuniti di Ancona, Ancona, Italy
UOC di Ematologia, Ospedale C e G Mazzoni, Ascoli Piceno, Italy
U.O. Ematologia con Trapianto, Policlinico di Bari, Bari, Italy
Ospedale Papa Giovanni XXIII, Bergamo, Italy
Ospedale Seragnoli Malpighi, Bologna, Italy
Ospedale Policlinico di Catania, TMO, Catania, Italy
Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy
Terapie Cellulari e Medicina Trasfusionale, Ospedale Careggi, Firenze, Italy
UO Ematologia, Programma Trapianti IRCCS Ospedale Policlinico San Martino, Genova, Genova, Italy
Centro Trapianto Fondazione IRCCS Cà Granda - Osp. Maggiore, Milano, Italy
Div. di Ematologia e TMO, Istituto Nazionale Tumori, Milano, Italy
Div. di Ematologia, Talamona, Osp. Niguarda, Ca-Granda, Milano, Italy
Istituto Clinico Humanitas, Oncologia ed Ematologia, Milano, Italy
Unità Operativa di Ematologia e Trapianto Midollo Osseo (UTMO), Ospedale San Raffaele di Milano, Milano, Italy
UOSC Ematologia con Trapianto CSE, AORN A. Cardarelli, AORN Cardarelli, Napoli, Italy
CTMO Osp. V. Cervello Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
Dip.di Ematologia, Osp. Civile di Pescara, Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico, Pescara, Italy
CTMO Centro Unico, Regionale Trapianti di Cellule Staminali e Terapie Cellulari, "A. Neri", Grande Osp. Bianchi, Melacrino Morelli, Reggio Calabria, Italy
SC di Ematologia Arcispedale, S. Maria Nuova AUSL-IRCCS, Reggio Emilia, Italy
Policlinico Tor Vergata, Roma, Italy
A.O.U. Citta della Salute e della Scienza, Torino, Italy
UOC di Ematologia, Osp. dell'Angelo, Venezia, Italy
Div. di Ematologia - Unità di TMO e Oncoematologia Pediatrica Policlinico GB Rossi, Verona, Italy
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT04623216
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Novartis Investigative Site, Bergamo, BG, Italy
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Brescia, BS, Italy
Novartis Investigative Site, Marseille, France
Novartis Investigative Site, Paris Cedex 10, France
Novartis Investigative Site, Freiburg, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Muenster, Germany
Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Las Palmas de Gran Canaria, Spain
Novartis Investigative Site, Madrid, Spain
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04086264
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Istituto di Ematologia "Lorenzo e A. Seragnoli" - Policlinco S. Orsola - Malpighi, Bologna, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy
Azienda Ospedaliera Universitaria Maggiore Della Carita Novara, Novara, Italy
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UC Irvine Medical Center, Orange, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
NewYork-Presbyterian - Weill Cornell, New York, New York, United States
Duke University Health System, Durham, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
MD Anderson, Houston, Texas, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Centre Antoine Lacassagne, Nice, France
University Hospital Leipzig, Leipzig, Germany
University Hospital of Ulm, Ulm, Germany
MD Anderson Cancer Center Madrid, Spain, Madrid, Spain
Hospital Universitario y Politécnico de La Fe, Valencia, Spain
TL-895 and KRT-232 Study in Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04669067
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
University Hospital - Ospedali Riuniti Umberto I - GM Lancisi - G Salesi of Ancona, Haematology Clinic, Ancona, Italy
Polyclinic S. Orsola-Malpighi, Operative Unit of Hematology, Bologna, Italy
Romagnolo Scientific Institute of Meldola (IRST) S.r.l., Department of Oncology and Clinical and Experimental Haematology, Meldola, Italy
Keck School of Medicine, Los Angeles, California, United States
University of California, Irvine Medical Center, Orange, California, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Rush University Medical Center, Division of Hematology Oncology and Cell Therapy, Chicago, Illinois, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Weill Cornell Medical College, New York, New York, United States
University of Cincinnati, Cincinnati, Ohio, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia, Pennsylvania, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
Box Hill Hospital, Melbourne, Australia
University of Sunshine Coast-Sippy Downs, Sippy Downs, Australia
Westmead Hospital, Sydney, Australia
Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
Medical University Vienna, Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology, Vienna, Austria
Claude Huriez Hospital, Lille, France
South Lyon Hospital Center, Lyon, France
Paoli-Calmettes Institute, Marseille, France
University Hospital of Nantes, Nantes, France
Hospital Center Universitaire De Nice, Nice, France
Saint-Louis Hospital, Paris, France
University Hospital Halle (Saale), Department of Internal Medicine IV - Hematology and Oncology, Halle, Sachsen-Anhalt, Germany
University Duisburg-Essen, University Hospital Essen, Department of Internal Medicine, Essen, Germany
University Hospital Hamburg-Eppendorf, Department of Internal Medicine II, Hamburg, Germany
University Hospital Jena, Clinic of Internal Medicine II, Department of Hematology and Medical Oncology, Jena, Germany
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Seoul National University Hospital, Department of Hemato-Oncology, Seoul, Korea, Republic of
University Hospital Germans Trias i Pujol, Department of Clinical Hematology, Badalona, Spain
University Hospital Vall d'Hebron, Barcelona, Spain
University Clinical Hospital of Valencia, Department of Hematology and Medical Oncology, Valencia, Spain
Hospital Universitario y Politécnico de La Fe, València, Spain
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04113616
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Universitaria Maggiore della Carità Novara, Novara, Piemonte, Italy
A.O.O.R. Villa Sofia Cervello, Palermo, Sicilia, Italy
AOU Policlinico S.Orsola-Malpighi, Bologna, Italy
AORMN Hospital Hematology and BMT Center, Pesaro, Italy
AOUS Le Scotte, Siena, Italy
Northwestern University, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
Mount Sinai, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Weill Cornell, New York, New York, United States
The Ohio State University, Columbus, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
MD Anderson Cancer Center, Houston, Texas, United States
Monash Health, Clayton, Australia
St. George Hospital, Kogarah, Australia
Royal Perth Hospital, Perth, Australia
Calvary Mater Newcastle Hospital, Waratah, Australia
Perth Blood Institute, West Perth, Australia
Institut Jules Bordet, Anderlecht, Belgium
Cliniques universitaires Saint-Luc, Brussels, Belgium
UZ Gent, Ghent, Belgium
Centre Hospitalier (CH) Jolimont, Haine-Saint-Paul, Belgium
CHU-UCL Namur site Godinne, Namur, Belgium
AZ Turnhout, Turnhout, Belgium
Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France
Institut Paoli Calmettes, Marseille, France
Centre Hospitalier Universitaire (CHU) de Nice, Nice, France
Hôpital Saint-Louis, Paris, France
Universitätsklinikum Halle, Halle, Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Universitätsklinikum Leipzig, Leipzig, Germany
Universitaetsklinikum Schleswig-Holstein, Lübeck, Germany
Semmelweis Egyetem, Budapest, Hungary
szabolcs-szatmár-bereg megyei kórházak és egyetemi oktatókórház Jósa András Oktatókórház, Debrecen, Hungary
Somogy Megyei KAposi Mor Oktato Korhaz, Kaposvár, Hungary
Rambam Health Care Campus, Haifa, Israel
Hadassah Medical Center Ein Kerem, Jerusalem, Israel
The Chaim Sheba Medical Center, Ramat Gan, Israel
Assaf Harofeh Medical Center AHMC, Tel Aviv, Israel
Inje University Busan Paik Hospital, Busan, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
The Catholic University of Korea-Seoul St. Mary's Hospital, Seoul, Korea, Republic of
Uniwersyteckie Centrum Kliniczne, Gdańsk, Poland
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas, Spain
MD Anderson Cancer Center, Madrid, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario Virgen de la Victoria de Málaga, Málaga, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain
University Hospital of Wales, Cardiff, United Kingdom
The Royal Marsden Hospital, London, United Kingdom
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Stato: In arruolamento
- Fascia d'età: Bambini, Adulti
- Codice Sperimentazione: NCT04240002
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Site IT39003, Bologna, Italy
Site IT39002, Monza, Italy
SIte IT39001, Roma, Italy
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Site CA15001, Montreal, Quebec, Canada
Site DE49002, Freiburg, Baden-Württemberg, Germany
Site DE49003, Regensburg, Bayern, Germany
Site DE49004, Essen, Nordrhein-Westfalen, Germany
Site DE49001, Halle (Saale), Sachsen-Anhalt, Germany
Site ES34001, Barcelona, Spain
Site ES34002, Barcelona, Spain
Site ES34003, Sevilla, Spain
Site GB44001, Birmingham, United Kingdom
Site GB44006, Bristol, United Kingdom
Site GB44005, Cardiff, United Kingdom
Site GB44003, Glasgow, United Kingdom
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT04161885
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 214910, Rome, Lazio, Italy
Ospedale San Raffaele IRCCS /ID# 214311, Milan, Lombardia, Italy
IEO -Istituto Europeo di Oncologia /ID# 242579, Milan, Milano, Italy
ASST Spedali civili di Brescia /ID# 215997, Brescia, Italy
A.O.U. Citta della Salute e della Scienza di Torino /ID# 216148, Turin, Italy
Arizona Oncology - Scottsdale - Cancer Transplant Institute Location /ID# 239711, Scottsdale, Arizona, United States
University of Arizona Cancer Center - Tucson /ID# 242507, Tucson, Arizona, United States
University of Arkansas for Medical Sciences /ID# 239804, Little Rock, Arkansas, United States
City of Hope /ID# 213681, Duarte, California, United States
University of California, Los Angeles /ID# 218199, Los Angeles, California, United States
UCHSC Anschultz Cancer Pavilion /ID# 215618, Aurora, Colorado, United States
Colorado Blood Cancer Institute /ID# 215980, Denver, Colorado, United States
Mayo Clinic /ID# 239710, Jacksonville, Florida, United States
AdventHealth Medical Group Blood & Marrow Transplant at Orlando /ID# 213985, Orlando, Florida, United States
Ann & Robert H Lurie Children's Hospital of Chicago /ID# 215840, Chicago, Illinois, United States
The University of Chicago Medical Center /ID# 215616, Chicago, Illinois, United States
Loyola University Medical Ctr /ID# 215617, Maywood, Illinois, United States
Indiana Blood & Marrow Transpl /ID# 215842, Indianapolis, Indiana, United States
Tulane Medical Center - New Orleans /ID# 239590, New Orleans, Louisiana, United States
Ochsner Clinic Foundation-New Orleans /ID# 213834, New Orleans, Louisiana, United States
Greenebaum Comprehensive Cancer Center - UM /ID# 213855, Baltimore, Maryland, United States
Massachusetts General Hospital /ID# 215765, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center /ID# 221181, Boston, Massachusetts, United States
Karmanos Cancer Institute - Dresner Clinic /ID# 214581, Detroit, Michigan, United States
Masonic Cancer Center /ID# 239492, Minneapolis, Minnesota, United States
Mayo Clinic - Rochester /ID# 214685, Rochester, Minnesota, United States
University of Mississippi Medical Center /ID# 239343, Jackson, Mississippi, United States
Saint Louis University Cancer Center /ID# 239633, Saint Louis, Missouri, United States
The John Theurer Cancer /ID# 215251, Hackensack, New Jersey, United States
Montefiore Medical Center - Moses Campus /ID# 241669, Bronx, New York, United States
Roswell Park Comprehensive Cancer Center /ID# 217857, Buffalo, New York, United States
Columbia University Medical Center /ID# 240875, New York, New York, United States
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 240680, New York, New York, United States
Weill Cornell Medical College /ID# 214887, New York, New York, United States
University of North Carolina /ID# 215814, Chapel Hill, North Carolina, United States
Wake Forest Univ HS /ID# 239210, Winston-Salem, North Carolina, United States
UC Health - Cincinnati /ID# 239263, Cincinnati, Ohio, United States
University Hospitals - Seidman Cancer Center /ID# 239260, Cleveland, Ohio, United States
University of Oklahoma, Stephenson Cancer Center /ID# 215611, Oklahoma City, Oklahoma, United States
Oregon Health & Science University /ID# 215874, Portland, Oregon, United States
Penn State Hershey Medical Ctr /ID# 217120, Hershey, Pennsylvania, United States
Children's Hospital of Philadelphia - Main /ID# 215410, Philadelphia, Pennsylvania, United States
Perelman Center for Advanced Medicine - /ID# 214518, Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center /ID# 241668, Philadelphia, Pennsylvania, United States
Allegheny General Hospital /ID# 216756, Pittsburgh, Pennsylvania, United States
UPMC Hillman Cancer Ctr /ID# 213715, Pittsburgh, Pennsylvania, United States
St Jude Children's Research Hospital /ID# 214074, Memphis, Tennessee, United States
TriStar Centennial Medical Center /ID# 218750, Nashville, Tennessee, United States
Texas Oncology - Medical City Dallas /ID# 216720, Dallas, Texas, United States
Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 213735, Dallas, Texas, United States
Texas Transplant Institute /ID# 214691, San Antonio, Texas, United States
University of Utah /ID# 238860, Salt Lake City, Utah, United States
Virginia Commonwealth University Medical Center Main Hospital /ID# 239203, Richmond, Virginia, United States
Fred Hutchinson Cancer Research Center /ID# 214436, Seattle, Washington, United States
Univ of Wisconsin Hosp/Clinics /ID# 216096, Madison, Wisconsin, United States
The Kinghorn Cancer Centre /ID# 214660, Darlinghurst, New South Wales, Australia
Royal Adelaide Hospital /ID# 215678, Adelaide, South Australia, Australia
Peter MacCallum Cancer Ctr /ID# 214653, Melbourne, Victoria, Australia
Alfred Health /ID# 240931, Melbourne, Victoria, Australia
Hospital de Clinicas de Porto Alegre /ID# 215042, Porto Alegre, Rio Grande Do Sul, Brazil
Hospital Amaral Carvalho /ID# 215145, Jaú, Sao Paulo, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo /ID# 239516, Sao Paulo, Brazil
Hospital Nove de Julho /ID# 242359, São Paulo, Brazil
Vancouver Coastal Health Research Institute (VCHRI) /ID# 215363, Vancouver, British Columbia, Canada
Ottawa Hospital Research Institute /ID# 238820, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre /ID# 215344, Toronto, Ontario, Canada
CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 214591, Montreal, Quebec, Canada
Royal Victoria Hospital / McGill University Health Centre /ID# 215253, Montreal, Quebec, Canada
Saskatoon Cancer Centre /ID# 238821, Saskatoon, Saskatchewan, Canada
Anhui Provincial Hospital /ID# 216408, Hefei, Anhui, China
Peking University People's Hospital /ID# 215551, Beijing, Beijing, China
Chinese PLA General Hospital /ID# 216287, Beijing, Beijing, China
Aerospace Center Hospital /ID# 217018, Beijing, Beijing, China
Fujian Medical University Union Hospital /ID# 215555, Fuzhou, Fujian, China
Guangdong Provincial People's Hospital /ID# 218666, Guangzhou, Guangdong, China
Zhujiang Hospital of Southern Medical University /ID# 216333, Guangzhou, Guangdong, China
Nanfang Hospital of Southern Medical University /ID# 215553, Guangzhou, Guangdong, China
Henan Cancer Hospital /ID# 215554, Zhengzhou, Henan, China
Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 215552, Wuhan, Hubei, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 238373, Wuhan, Hubei, China
Zhongda Hospital Southeast University /ID# 218926, Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University /ID# 216605, Suzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University /ID# 239098, Xuzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University /ID# 239168, Nanchang, Jiangxi, China
Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 216282, Xi'an, Shaanxi, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 239317, Shanghai, Shanghai, China
Shanghai Changhai Hospital /ID# 216334, Shanghai, Shanghai, China
Shanghai General Hospital /ID# 216410, Shanghai, Shanghai, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 215546, Tianjin, Tianjin, China
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 215550, Hangzhou, Zhejiang, China
Xiangya Hospital Central South University /ID# 219025, Changsha, China
Fakultni Nemocnice Brno /ID# 214811, Brno, Czechia
Fakultni nemocnice Hradec Kralove /ID# 214814, Hradec Kralove, Czechia
Fakultni nemocnice Ostrava /ID# 239922, Ostrava, Czechia
Ustav hematologie a krevni transfuze /ID# 215133, Praha, Czechia
CHU de Nice - Hôpital Archet 1 /ID# 214056, Nice, Alpes-Maritimes, France
CHU de Besancon - Jean Minjoz /ID# 241171, Besancon, Doubs, France
CHU Bordeaux - Hopital Haut Leveque /ID# 214055, Pessac CEDEX, Gironde, France
CHRU Lille - Hopital Claude Huriez /ID# 217916, Lille, Hauts-de-France, France
CHU de Nantes, Hotel Dieu -HME /ID# 214060, Nantes, Pays-de-la-Loire, France
AP-HP - Hopital Saint-Louis /ID# 214054, Paris, France
AP-HP - Hopital Saint-Antoine /ID# 216957, Paris, France
Hopital Pitie Salpetriere /ID# 241072, Paris, France
Universitaetsklinik Heidelberg /ID# 216623, Heidelberg, Baden-Wuerttemberg, Germany
Universitaetsklinikum Muenster /ID# 215213, Muenster, Nordrhein-Westfalen, Germany
Universitaetsklinikum Leipzig /ID# 245892, Leipzig, Sachsen, Germany
Klinikum Augsburg /ID# 239583, Augsburg, Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 214244, Dresden, Germany
Universitaetsklinikum Halle (Saale) /ID# 239585, Halle (Saale), Germany
Medizinische Hochschule Hannover /ID# 214243, Hannover, Germany
Universitaetsklinikum Wuerzburg /ID# 215212, Wuerzburg, Germany
General Hospital of Athens Evangelismos /ID# 238810, Athens, Attiki, Greece
University General Hospital Attikon /ID# 238812, Athens, Attiki, Greece
University General Hospital of Patras /ID# 238811, RION Patras Achaia, Greece
Debreceni Egyetem Klinikai Kozpont /ID# 241123, Debrecen, Hajdu-Bihar, Hungary
The Chaim Sheba Medical Center /ID# 214305, Ramat Gan, Tel-Aviv, Israel
Tel Aviv Sourasky Medical Center /ID# 214508, Tel Aviv-Yafo, Tel-Aviv, Israel
Rambam Health Care Campus /ID# 214507, Haifa, Israel
Hadassah Medical Center-Hebrew University /ID# 218697, Jerusalem, Israel
Schneider Children's Medical Center /ID# 224326, Petah Tikva, Israel
Rabin Medical Center /ID# 214509, Petakh Tikva, Israel
Sheba Medical Center /ID# 239571, Tel Hashomer, Ramat Gan, Israel
Anjou Kousei Hospital /ID# 215857, Anjo-shi, Aichi, Japan
Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital /ID# 215679, Nagoya-shi, Aichi, Japan
Kyushu University Hospital /ID# 215285, Fukuoka-shi, Fukuoka, Japan
Hokkaido University Hospital /ID# 215937, Sapporo-shi, Hokkaido, Japan
Kobe City Medical Center General Hospital /ID# 215388, Kobe-shi, Hyogo, Japan
Hyogo College of Medicine College Hospital /Id# 215389, Nishinomiya-shi, Hyogo, Japan
Kanazawa University Hospital /ID# 242955, Kanazawa-shi, Ishikawa, Japan
Imamura General Hospital /ID# 215688, Kagoshima-shi, Kagoshima, Japan
Kanagawa Cancer Center /ID# 215029, Yokohama-shi, Kanagawa, Japan
Kyoto University Hospital /ID# 243209, Kyoto-shi, Kyoto, Japan
Tohoku University Hospital /ID# 214670, Sendai-shi, Miyagi, Japan
Okayama University Hospital /ID# 214842, Okayama-shi, Okayama, Japan
Osaka Metropolitan University Hospital /ID# 215227, Osaka-shi, Osaka, Japan
Kindai University Hospital /ID# 214917, Osakasayama-shi, Osaka, Japan
Jichi Medical University Saitama Medical Center /ID# 216092, Saitama-shi, Saitama, Japan
Jichi Medical University Hospital /ID# 216091, Shimotsuke-shi, Tochigi, Japan
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital /ID# 215939, Bunkyo-ku, Tokyo, Japan
National Cancer Center Hospital /ID# 242639, Chuo-ku, Tokyo, Japan
Toranomon Hospital /ID# 215311, Minato-ku, Tokyo, Japan
National Center for Child Health and Development /ID# 242479, Setagaya-ku, Tokyo, Japan
Keio University Hospital /ID# 243549, Shinjuku-ku, Tokyo, Japan
Seoul National University Hospital /ID# 214891, Seoul, Korea, Republic of
Asan Medical Center /ID# 214893, Seoul, Korea, Republic of
Samsung Medical Center /ID# 239087, Seoul, Korea, Republic of
The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 214892, Seoul, Korea, Republic of
Rogachev Nat Med Research Ctr for Pediatric Hematology, Onc /ID# 216538, Moscow, Moskva, Russian Federation
Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 214609, St. Petersburg, Sankt-Peterburg, Russian Federation
Kirov Research Institute of Hematology and Blood Transfusion of FMBA /ID# 216591, Kirov, Russian Federation
Clinic of Immunopathology, SRIFCI /ID# 215201, Novosibirsk, Russian Federation
Almazov National Medical Research Centre /ID# 214357, Sankt-Peterburg, Russian Federation
Hospital Clinic de Barcelona /ID# 215108, Barcelona, Spain
Hospital Santa Creu i Sant Pau /ID# 240397, Barcelona, Spain
Hospital General Universitario Gregorio Maranon /ID# 215107, Madrid, Spain
Hospital Universitario Ramon y Cajal /ID# 218102, Madrid, Spain
Hospital Universitario La Paz /ID# 218103, Madrid, Spain
Hospital Universitario Virgen del Rocio /ID# 215463, Sevilla, Spain
Hospital Clinico Universitario de Valencia /ID# 215106, Valencia, Spain
Universitätsspital Basel /ID# 215892, Basel, Basel-Stadt, Switzerland
Universitätsspital Zürich /ID# 215891, Zürich, Zuerich, Switzerland
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 215197, Kaohsiung, Taiwan
China Medical University Hospital /ID# 215198, Taichung City, Taiwan
Taichung Veterans General Hospital /ID# 239288, Taichung, Taiwan
National Taiwan University Hospital /ID# 215245, Taipei City, Taiwan
Taipei Veterans General Hosp /ID# 239289, Taipei City, Taiwan
Linkou Chang Gung Memorial Hospital /ID# 215319, Taoyuan City, Taiwan
University Hospital Southampton NHS Foundation Trust /ID# 244849, Southampton, Hampshire, United Kingdom
NHS Greater Glasgow and Clyde /ID# 215663, Glasgow, Scotland, United Kingdom
University Hospitals Birmingham NHS Foundation Trust /ID# 215120, Birmingham, United Kingdom
University College London Hospitals NHS Foundation Trust /ID# 215662, London, United Kingdom
King's College Hospital NHS Foundation Trusts /ID# 215338, London, United Kingdom
The Royal Marsden NHS Foundation Trust /ID# 215124, London, United Kingdom
Imperial College Healthcare NHS Trust /ID# 215665, London, United Kingdom
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT03860844
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Investigational Site Number :3800001, Monza, Lombardia, Italy
Investigational Site Number :3800002, Genova, Italy
Investigational Site Number :3800004, Roma, Italy
Investigational Site Number :3800003, Torino, Italy
Investigational Site Number :3800005, Verona, Italy
Investigational Site Number :8400004, Cincinnati, Ohio, United States
Investigational Site Number :8400001, Nashville, Tennessee, United States
Investigational Site Number :8400002, Dallas, Texas, United States
Investigational Site Number :8400003, Seattle, Washington, United States
Investigational Site Number :0320002, Caba, Buenos Aires, Argentina
Investigational Site Number :0320003, Caba, Buenos Aires, Argentina
Investigational Site Number :0320006, Capital Federal, Buenos Aires, Argentina
Investigational Site Number :0320005, Buenos Aires, Argentina
Investigational Site Number :0320004, Buenos Aires, Argentina
Investigational Site Number :0320001, Córdoba, Argentina
Investigational Site Number :0560001, Leuven, Belgium
Investigational Site Number :0760013, Curitiba, Paraná, Brazil
Investigational Site Number :0760006, Curitiba, Paraná, Brazil
Investigational Site Number :0760007, Porto Alegre, Rio Grande Do Sul, Brazil
Investigational Site Number :0760010, Jau, São Paulo, Brazil
Investigational Site Number :0760009, Ribeirão Preto, São Paulo, Brazil
Investigational Site Number :0760004, Sao Paulo, São Paulo, Brazil
Investigational Site Number :0760001, Sao Paulo, São Paulo, Brazil
Investigational Site Number :1240001, Vancouver, British Columbia, Canada
Investigational Site Number :2030002, Brno, Czechia
Investigational Site Number :2030001, Praha 5 - Motol, Czechia
Investigational Site Number :2080001, Copenhagen, Denmark
Investigational Site Number :2460001, Tampere, Finland
Investigational Site Number :2500005, Bordeaux, France
Investigational Site Number :2500002, Lille, France
Investigational Site Number :2500003, Lyon, France
Investigational Site Number :2500001, PARIS Cedex 12, France
Investigational Site Number :2500004, PARIS Cedex 19, France
Investigational Site Number :2760005, Erlangen, Germany
Investigational Site Number :2760001, Essen, Germany
Investigational Site Number :2760004, Halle (Saale), Germany
Investigational Site Number :2760003, Hamburg, Germany
Investigational Site Number :2760006, Münster, Germany
Investigational Site Number :3000001, Athens, Greece
Investigational Site Number :3480002, Budapest, Hungary
Investigational Site Number :3480001, Debrecen, Hungary
Investigational Site Number :4100001, Seoul, Seoul-teukbyeolsi, Korea, Republic of
Investigational Site Number :4100003, Seoul, Seoul-teukbyeolsi, Korea, Republic of
Investigational Site Number :4100002, Seoul, Seoul-teukbyeolsi, Korea, Republic of
Investigational Site Number :4100004, Seoul, Seoul-teukbyeolsi, Korea, Republic of
Investigational Site Number :4840005, Queretaro, Querétaro, Mexico
Investigational Site Number :4840001, Monterrey, Nuevo León, Mexico
Investigational Site Number :5280001, Utrecht, Netherlands
Investigational Site Number :5780001, Bergen, Norway
Investigational Site Number :5780002, Oslo, Norway
Investigational Site Number :6040001, Arequipa, Peru
Investigational Site Number :6040002, Lima, Peru
Investigational Site Number :6200002, Coimbra, Portugal
Investigational Site Number :6200001, Lisboa, Portugal
Investigational Site Number :6200003, Porto, Portugal
Investigational Site Number :7520001, Göteborg, Sweden
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04589728
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
Aou Careggi - Firenze - Sod Ematologia, Firenze, Italy
Aou Ospedali Riuniti - Foggia - Uoc Ematologia, Foggia, Italy
Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy
Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora, Milano, Italy
Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia, Milano, Italy
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, Pagani, Italy
Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy
Ao Regionale S. Carlo - Potenza - Sic Ematologia, Potenza, Italy
Aou Policlinico Tor Vergata - Roma - Uoc Trapianto Cellule Staminali, Roma, Italy
Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche, Salerno, Italy
Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia, Sassari, Italy
Ospedale Di Sassuolo Spa - Ematologia, Sassuolo, Italy
Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy
Asl Di Viterbo, Complesso Ospedaliero Di Belcolle - Uoc Ematologia, Viterbo, Italy
Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04912063
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Istituto Clinico Humanitas /ID# 226948, Rozzano, Milano, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 226950, Bologna, Italy
ASST Grande Ospedale Metropolitano Niguarda /ID# 226952, Milano, Italy
University of Alabama at Birmingham - Main /ID# 227071, Birmingham, Alabama, United States
University of California, Los Angeles /ID# 227752, Los Angeles, California, United States
The University of Chicago Medical Center /ID# 228689, Chicago, Illinois, United States
Norton Cancer Institute - St Matthews /ID# 228378, Louisville, Kentucky, United States
Massachusetts General Hospital /ID# 227273, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center /ID# 231083, Boston, Massachusetts, United States
University of Michigan /ID# 227030, Ann Arbor, Michigan, United States
Oregon Health and Science University /ID# 227121, Portland, Oregon, United States
University of Pennsylvania /ID# 227024, Philadelphia, Pennsylvania, United States
UPMC Hillman Cancer Ctr /ID# 228048, Pittsburgh, Pennsylvania, United States
MD Anderson Cancer Center at Texas Medical Center /ID# 227019, Houston, Texas, United States
University of Virginia Health /ID# 227363, Charlottesville, Virginia, United States
Liverpool Hospital /ID# 227723, Liverpool, New South Wales, Australia
Austin Health /ID# 227717, Heidelberg, Victoria, Australia
Tom Baker Cancer Centre /ID# 227863, Calgary, Alberta, Canada
Juravinski Cancer Centre /ID# 227867, Hamilton, Ontario, Canada
Marien Hospital Duesseldorf /ID# 227751, Duesseldorf, Nordrhein-Westfalen, Germany
Universitaetsklinikum Leipzig /ID# 227750, Leipzig, Sachsen, Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 227749, Dresden, Germany
Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 227748, Hamburg, Germany
The Chaim Sheba Medical Center /ID# 227389, Ramat Gan, Tel-Aviv, Israel
Tel Aviv Sourasky Medical Center /ID# 227387, Tel Aviv-Yafo, Tel-Aviv, Israel
Hadassah Medical Center-Hebrew University /ID# 227275, Jerusalem, Israel
Rabin Medical Center /ID# 227738, Petakh Tikva, Israel
National Cancer Center Hospital East /ID# 232498, Kashiwa-shi, Chiba, Japan
University of Fukui Hospital /ID# 232466, Yoshida-gun, Fukui, Japan
Kyushu University Hospital /ID# 232564, Fukuoka-shi, Fukuoka, Japan
Yamagata University Hospital /ID# 232451, Yamagata-shi, Yamagata, Japan
Hospital Clinic de Barcelona /ID# 227772, Barcelona, Spain
Hospital Universitario Fundacion Jimenez Diaz /ID# 227771, Madrid, Spain
Hospital Universitario Virgen de la Victoria /ID# 227770, Malaga, Spain
King's College Hospital NHS Foundation Trusts /ID# 229572, London, United Kingdom
The Christie Hospital /ID# 229578, Manchester, United Kingdom
Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Stato: In arruolamento
- Fascia d'età: Bambini, Adulti
- Codice Sperimentazione: NCT03793478
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Fondazione MBBM - Clinica Pediatrica, Monza, Italy
IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
Ospedale Infantile Regina Margherita, Torino, Italy
Loma Linda University Cancer Center, Loma Linda, California, United States
University of California, San Francisco, San Francisco, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
A.I. duPont Hospital for Children, Wilmington, Delaware, United States
Children's National Medical Center, Washington, District of Columbia, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Riley Hospital for Children - Indiana University, Indianapolis, Indiana, United States
Johns Hopkins, Baltimore, Maryland, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Columbia University/Herbert Irving Cancer Center, New York, New York, United States
New York Medical College, Valhalla, New York, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
The University of Texas Southwestern Medical Center Children's Health, Dallas, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
Universitair Ziekenhuis Gent, Gent, Belgium
The Hospital for Sick Children, Toronto, Ontario, Canada
Montreal Children's Hospital, Montréal, Quebec, Canada
British Columbia Children's Hospital, Vancouver, Canada
Rigshospitalet, Copenhagen, Denmark
Centre Léon Bérard, Lyon, France
Hôpital Armand-Trousseau, Paris, France
Hôpital des Enfants, Toulouse, France
Rambam Medical Center, Haifa, Israel
Schneider Children's Medical Center of Israel, Petah Tikva, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel
Prinses Maxima Centrum voor Kinderoncologie, Utrecht, Netherlands
Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Sahlgrenska Universitetssjukhuset - Drottning Silvias Barn- och Ungdomssjukhus, Göteborg, Sweden
NHS Greater Glasgow and Clyde - The Queen Elizabeth University Hospital, Glasgow, United Kingdom
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03455504
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Ematologia - ASST Papa Giovanni XXIII, Bergamo, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Spedali Civili - Azienda Ospedaliera U.O. Ematologia, Brescia, Italy
Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy
A.O.U. Careggi - Ematologia, Firenze, Italy
Irccs Aou San Martino - Genova - Uo Clinica Ematologica, Genova, Italy
Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori IRST, Meldola, Italy
Fondazione Irccs "Istituto Nazionale Tumori" - Milano - Sc Ematologia, Milano, Italy
Ospedale Niguarda "Ca Granda" SC Ematologia, Milano, Italy
U.O. Ematologia e Trapianto di Midollo Ist. Scientifico Ospedale San Raffaele, Milano, Italy
Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, Pagani, Italy
U.O.C. Ematologia e CTMO Az Ospedaliero Universitaria, Parma, Italy
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy
Dipartimento Oncologico - Ospedale S. Maria delle Croci, Ravenna, Italy
Università degli Studi "Sapienza" Dip. Biotecnologie Cellulari ed Ematologia, Roma, Italy
Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia, Roma, Italy
Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica Ed Ematologia, Rozzano, Italy
Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche, Salerno, Italy
Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino, Torino, Italy
Dipartimento di Oncologia ed Ematologia S.C. -Città della Scienza di Torino San Giovanni Battista, Torino, Italy
Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia, Vicenza, Italy
Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03922100
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
ASST Papa Giovanni XXIII, Bergamo, BG, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
Istituto Clinico Humanitas, Rozzano, MI, Italy
Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Italy
ASST Spedali Civili di Brescia, Brescia, Italy
A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04580121
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
ASST PAPA GIOVANNI XXIII; Ematologia, Bergamo, Lombardia, Italy
Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia, Rozzano, Lombardia, Italy
Ospedale Santa Chiara; Unita Operativa Di Ematologia, Pisa, Toscana, Italy
City of Hope, Duarte, California, United States
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Washington University; Wash Uni. Sch. Of Med, Saint Louis, Missouri, United States
Peter MacCallum Cancer Centre; Medical Oncology, Melbourne, Victoria, Australia
The Alfred, Melbourne, Victoria, Australia
Princess Margaret Cancer Center, Toronto, Ontario, Canada
Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT, København Ø, Denmark
Institut Paoli Calmettes; Departement D' Onco-Hematologie, Marseille, France
Hopital De Haut Leveque; Hematologie Clinique, Pessac, France
Universitätsklinikum "Carl Gustav Carus"; Medizinische Klinik und Poliklinik I, Dresden, Germany
Klinikum der Universität München, Campus Großhadern; Medizinische Klinik und Poliklinik III, München, Germany
Institut Catala d´Oncologia Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital Universitari Vall d'Hebron; Servicio de Hematologia, Barcelona, Spain
Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, Spain
Hospital Univ. 12 de Octubre; Servicio de Hematologia, Madrid, Spain
Hospital Universitario la Fe; Servicio de Hematologia, Valencia, Spain
China Medical University Hospital; Oncology and Hematology, Taichung, Taiwan
National Cheng Kung University Hospital; Oncology, Tainan, Taiwan
National Taiwan Universtiy Hospital; Division of Hematology, Taipei, Taiwan
Churchill Hospital, Oxford, United Kingdom
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03940352
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Duke University Medical Center, Durham, North Carolina, United States
Novartis Investigative Site, Melbourne, Victoria, Australia
Novartis Investigative Site, Helsinki, Finland
Novartis Investigative Site, Heidelberg, Germany
Novartis Investigative Site, Wuerzburg, Germany
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Basel, Switzerland
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03250338
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Policlinico Tor Vergata, Roma, RM, Italy
AOU Policlinico Sant'Orsola-Malpighi, Bologna, Italy
ASST Spedali Civili di Brescia, Brescia, Italy
AOU Careggi, Firenze, Italy
IRST - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
IRCCS Foundation Ca 'Granda Ospedale Maggiore Policlinico, Milano, Italy
Istituto Europeo di Oncologia, Milano, Italy
IRCCS San Raffaele Hospital, Milan, Italy
Aorn Antonio Cardarelli, Napoli, Italy
AOU Federico II, Napoli, Italy
AOU Maggiore della Carità, Novara, Italy
AO Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
AO Ospedali Riuniti Marche Nord, Pesaro, Italy
Ospedale Santa Maria delle Croci di Ravenna, Ravenna, Italy
Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
AO Ordine Mauriziano di Torino, Torino, Italy
Policlinico GB Rossi, University Hospital Verona, Verona, Italy
AULSS n 8 Berica Ospedale San Bortolo, Vicenza, Italy
City of Hope National Medical Center, Sacramento, California, United States
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
University of Florida, Gainesville, Florida, United States
University of Chicago, Chicago, Illinois, United States
Kansas University, Kansas City, Kansas, United States
Karmanos Cancer Center, Detroit, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
University of Alberta, Edmonton, Alberta, Canada
Hospital Avicenne, Bobigny, France
CHU Grenoble Alpes, Grenoble, France
Hospital Center of Versailles (Le Chesnay), Le Chesnay, France
Hospital Claude Huriez - Chru Lille, Lille, France
Institut Paoli-Calmettes, Marseille, France
CHU de Nantes - Hôtel Dieu, Nantes, France
University Hospital Nice L'Archet, Nice, France
Hôpital St Louis, Paris, France
CHU de Bordeaux, Pessac, France
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
CHU de Poitiers, Poitiers, France
Institut Universitaire du Cancer Toulouse, Toulouse, France
Klinikum Chemnitz gGmbH, Chemnitz, Germany
Technische Universität Dresden, Dresden, Germany
Universitätsklinikum Essen (AöR), Essen, Germany
Universitätsklinikum Frankfurt, Frankfurt, Germany
Universitätsklinikum Halle (Saale), Halle, Germany
Universitätsklinikum Münster, Münster, Germany
Hospital U. Virgen del Rocio, Sevilla, Andalucia, Spain
Hospital Universitario Central de Asturias (HUCA), Oviedo, Asturias, Spain
Complejo Hospitalario Universitario A Coruna, A Coruña, Spain
San Pedro de Alcantara Hospital, Cáceres, Spain
Reina Sofia University Hospital, Córdoba, Spain
Hospital Universitario de Donostia, Donostia San Sebastian, Spain
Hospital Ramon y Cajal, Madrid, Spain
Fundacion Jimenez Diaz, Madrid, Spain
Hospital 12 de Octubre, Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Gregorio Maranon Servicio de Hematologia y Hemoterapia, Madrid, Spain
Hospital Clinico Universitario de Salamanca, Salamanca, Spain
Hospital U. Marques de Valdecilla, Santander, Spain
Hospital Clinico Universitario de Santiago, Santiago De Compostela, Spain
Hospital Universitario y Politecnico La Fe, Valencia, Spain
A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04150029
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
25University of Alabama at Birmingham, Birmingham, Alabama, United States
UCSF Medical Center, San Francisco, California, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Georgia Regents University, Augusta, Georgia, United States
University of Iowa Hospitals and Clinics Univ of Iowa Hosp & Clinic, Iowa City, Iowa, United States
Dana Farber Cancer Institute Dana Farber Cancer Int, Boston, Massachusetts, United States
Mayo Clinic Dept. of Mayo Clinic (2), Rochester, Minnesota, United States
Memorial Sloan Kettering Dept. of MSKCC, New York, New York, United States
Weill Cornell Medicine NewYork Presbyterian Hospital, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Chattanooga Oncology and Hematology Associates PC Tennessee Oncology Chattanooga, Chattanooga, Tennessee, United States
MD Anderson Cancer Center/University of Texas MD Anderson, Houston, Texas, United States
Huntsman Cancer Institute Univ of Utah, Salt Lake City, Utah, United States
Novartis Investigative Site, Clayton, Victoria, Australia
Novartis Investigative Site, Vancouver, British Columbia, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Paris Cedex 10, France
Novartis Investigative Site, Toulouse, France
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Leipzig, Germany
Novartis Investigative Site, Fukushima city, Fukushima, Japan
Novartis Investigative Site, Yamagata, Japan
Novartis Investigative Site, Seoul, Seocho Gu, Korea, Republic of
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Kaohsiung City, Taiwan
Novartis Investigative Site, Taoyuan, Taiwan
Gemtuzumab Chemotherapy MRD Levels; Glasdegib Post-transplant, Adult Untreated, de Novo, Fav Interm Risk AML
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT04168502
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia, Alessandria, Italy
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia, Ascoli Piceno, Italy
AO "San Giuseppe Moscati" - UOC Ematologia con unità di trapianto, Avellino, Italy
AOU Consorziale Policlinico "Aldo Moro" - UO Ematologia con trapianto, Bari, Italy
Policlinico S. Orsola - Malpighi - UOC Ematologia, Bologna, Italy
Ao Sant'Anna E San Sebastiano - Caserta - Uoc Onco Ematologia, Caserta, Italy
U.O.C. Oncoematologia - Istituto Oncologico Veneto Irccs, Presidio Ospedaliero S. Giacomo Apostolo, Castelfranco Veneto, Italy
Asur Marche Area Vasta 3 - Presidio Ospedaliero Civitanova Marche - Uods Ematologia, Civitanova Marche, Italy
Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione, Cona, Italy
Asst Di Cremona - Ospedale Di Cremona - Uo Ematologia, Cremona, Italy
Aou Careggi - Firenze - Sod Ematologia, Firenze, Italy
Asl Frosinone, Ospedale F. Spaziani - Ematologia, Frosinone, Italy
Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti, Genova, Italy
Presidio Ospedaliero Nord "Santa Maria Goretti" - UOC Ematologia, Latina, Italy
ASL Le/1 P.O. Vito Fazzi - UO Ematologia, Lecce, Italy
Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia, Milano, Italy
ISTITUTO EUROPEO DI ONCOLOGIA IRCCS - MILANO - DIVISIONE DI ONCOEMATOLOGIA 176 Milano Divisione di Onco-Ematologia Istituto Europeo, Milano, Italy
Aou Di Modena - Sc Ematologia, Modena, Italy
Ao Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Ematologia Con Trapianto Di Midollo, Napoli, Italy
Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, Pagani, Italy
Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
Ao Ospedali Riuniti Marche Nord - Ospedale San Salvatore - Pesaro - Uoc Ematologia E Centro Trapianti, Pesaro, Italy
Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy
Asl Di Piacenza, Ospedale "Guglielmo Da Saliceto" - Ematologia E Centro Trapianti, Piacenza, Italy
Ausl Della Romagna, Ospedale "Santa Maria Delle Croci" - Ravenna - Ematologia, Ravenna, Italy
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia, Reggio Emilia, Italy
Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy
Ao Complesso Ospedaliero San Giovanni / Addolorata - Roma - Uoc Ematologia, Roma, Italy
AOU Policlinico Tor Vergata- UOC Trapianto cellule staminali, Roma, Italy
Aou Sant'Andrea - Roma - Uoc Ematologia, Roma, Italy
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, Roma, Italy
Istituti Fisioterapici Ospitalieri - Ifo - Istituto Regina Elena - Roma - Uosd Ematologia, Roma, Italy
Policlinico Universitario Campus Bio Medico - Roma - Uoc Ematologia E Trapianto Di Cellule Staminali, Roma, Italy
Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia, Roma, Italy
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy
Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia, Sassari, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy
Unità Operativa Di Ematologia - Presidio Ospedaliero Di Treviso - Azienda Ulss N.2 Marca Trevigiana, Treviso, Italy
Azienda Sanitaria Universitaria Integrata Di Trieste - Sc Ematologia, Trieste, Italy
Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT01570465
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
U.O. di Medicina Interna - ASUR Marche 8 - Ospedale Civile, Civitanova Marche, Ancona, Italy
S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Azienda Ospedaliera - Nuovo Ospedale "Torrette", Ancona, Italy
UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari, Bari, Italy
Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy
Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy
U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche, Campobasso, Italy
U.O.C. di Onco-Ematologia - A.O. S.Anna e S.Sebastiano, Caserta, Italy
Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy
Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia, Catanzaro, Italy
Sezione di Ematologia C.T.M.O. Istituti Ospitalieri, Cremona, Italy
Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna, Ferrara, Italy
Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, Foggia, Italy
Divisione di Ematologia Ospedale "Santa Maria Goretti", Latina, Italy
ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy
Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte", Messina, Italy
Ospedale Niguarda ' Ca Granda', Milano, Italy
UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico, Milano, Italy
Centro Oncologico Modenese - Dipartimento di Oncoematologia, Modena, Italy
Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Napoli, Italy
Ospedale San Gennaro - ASL Napoli 1, Napoli, Italy
Nocera Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I, Nocera Inferiore, Italy
Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga, Orbassano, Italy
U.O. di Oncoematologia -plesso ospedaliero "A. Tortora" di Pagani, Pagani, Italy
Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy
Cattedra di Ematologia CTMO Università degli Studi di Parma, Parma, Italy
Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore, Pesaro, Italy
U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy
Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, Piacenza, Italy
Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia, Pisa, Italy
Ematologia - Ospedale San Carlo, Potenza, Italy
Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, Reggio Emilia, Italy
A.O. "Sant'Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia, Roma, Italy
Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo, Roma, Italy
Policlinico di Tor Vergata, Roma, Italy
Roma Complesso Ospedaliero S. Giovanni Addolorata, Roma, Italy
S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy
U.O.C. Ematologia - Ospedale S.Eugenio, Roma, Italy
Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy
UOC Medicina Trasfusionale e Cellule Staminali Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
Serv. di Ematologia Ist. di Ematologia ed Endocrinologia, Sassari, Italy
Azienda U.L.S.S.9 - U.O. di Ematologia, Treviso, Italy
U.O. di Ematologia - Azienda Ospedaliera - Pia Fondazione di Culto e di Religione Card. G.Panico, Tricase, Italy
Clinica Ematologica - Policlinico Universitario, Udine, Italy
Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03306264
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy
AOUC Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
Fondazione IRCCS C Granda OM Policlinico, Milan, Italy
Azienda Ospedaliero-Universitaria Maggiore della Carità Novara, Novara, Italy
Ospedale S. Eugenio, Rome, Italy
ULSS 8 Vicenza - Ospedale San Bortolo di Vicenza, Vicenza, Italy
Pinnacle Research Group, Anniston, Alabama, United States
Mayo Clinic Arizona, Phoenix, Arizona, United States
Arizona Clinical Research Center, Tucson, Arizona, United States
Compassionate Cancer Care Research Group, Fountain Valley, California, United States
University of Southern California, Los Angeles, California, United States
Yale, New Haven, Connecticut, United States
Georgetown University, Washington, District of Columbia, United States
Boca Raton Clinical Research, Boca Raton, Florida, United States
Holy Cross Hospital, Fort Lauderdale, Florida, United States
Mount Sinai, Miami Beach, Florida, United States
Rush University Medical Center, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
Quincy Medical Group, Quincy, Illinois, United States
Indiana Blood and Marrow Transplantation, Indianapolis, Indiana, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Johns Hopkins, Baltimore, Maryland, United States
Regional Cancer Care Associates, Bethesda, Maryland, United States
Michigan Center of Medical Research, Farmington Hills, Michigan, United States
Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Hackensack, Hackensack, New Jersey, United States
Montefiore, Bronx, New York, United States
Roswell Park, Buffalo, New York, United States
Monter Cancer Center, Lake Success, New York, United States
Weill Cornell Medicine, New York, New York, United States
Gabrail Cancer Center, Canton, Ohio, United States
Ohio State University, Columbus, Ohio, United States
Oregon Health & Sciences University, Portland, Oregon, United States
West Penn Allegheny Cancer Institute, Pittsburgh, Pennsylvania, United States
University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Charleston Hematology Oncology Associates, Charleston, South Carolina, United States
Vanderbilt, Nashville, Tennessee, United States
Baylor Scott & White University Medical Center, Dallas, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Houston Methodist Cancer Center, Houston, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Utah Cancer Specialists, Salt Lake City, Utah, United States
Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Uniklinikum Salzburg, Salzburg, Austria
General Hospital Hietzing, Vienna, Austria
Klinikum Wels-Grieskirchen, Wels, Austria
University of Alberta Hospital, Edmonton, Alberta, Canada
Queen Elizabeth II (QEII) Health Sciences Center, Halifax, Nova Scotia, Canada
Juravinski Hospital & Cancer Center, Hamilton, Ontario, Canada
Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Princess Margaret Cancer Center - University Health Network, Toronto, Ontario, Canada
Centre Intégré Universitaire de Santé et de Services Sociaux (CIUSSS) de l'Est-de-l'Ile-de-Montréal - Hôpital Maisonneuve Rosemont, Montréal, Quebec, Canada
FN Ostrava, Ostrava, Poruba, Czechia
Fakultni Nemocnice Kralovske Vinohrady FNKV, Praha 10, Česká Republika, Czechia
Centre de lutte contre le Cancer Leon Berard, Lyon, Rhone, France
Hospital Emile Muller, Mulhouse, France
Universitaetsklinikum Freiburg, Freiburg im Breisgau, Baden, Germany
Philipps-Universität Marburg, Klinik für Innere medizin, Hämatologie, Onkologie und Immunologie, Marburg, Hesse, Germany
UNIVERSITTSKLINIKUM Schleswig-Holstein, Lubeck, Schleswig-Holstein, Germany
Staedtisches Klinikum Braunschweig, Braunschweig, Germany
Oberärztin für Innere Medizin, Hämato-/Onkologie und Palliativmedizin, Düsseldorf, Germany
University Hospital Halle, Halle, Germany
University of Leipzig, Leisnig, Germany
Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary
Somogy Megyei KAposi Mor Oktato Korhaz, Kaposvár, Hungary
University of Pecs, 1st Department of Internal Medicine, Pecs, Hungary
University of Szeged, Szeged, Hungary
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
Hospital U. Marqués de Valdecilla, Santander, Cantabria, Spain
Hospital San Pedro de Alcantara, Cáceres, Spain
Hospital Universitario Virgen de las Nieves, Granada, Spain
Hospital Duran i Reynals, L'Hospitalet De Llobregat, Spain
Hospital General Universitario Gregorio Marañón, Madrid, Spain
Clinica Universitaria Navarra, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Clinica Universitaria Navarra, Pamplona, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Hospital Universitari I Politècnic La Fe, València, Spain
Oxford University Hopsitals NHS Trust, Oxford, Oxfordshire, United Kingdom
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05168202
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Local Institution, Meldola, Italy
Local Institution, Milan, Italy
Local Institution, Rozzano, Italy
Local Institution, Marina Del Rey, California, United States
Local Institution, Stanford, California, United States
Local Institution, Miami, Florida, United States
Local Institution, Chicago, Illinois, United States
Local Institution, Buffalo, New York, United States
Local Institution, Houston, Texas, United States
Local Institution, Seattle, Washington, United States
Local Institution, Wollongong, New South Wales, Australia
Local Institution, Clayton, Victoria, Australia
Local Institution, Fitzroy, Victoria, Australia
Local Institution, Heidelberg, Victoria, Australia
Local Institution, Edmonton, Alberta, Canada
Local Institution, Vancouver, British Columbia, Canada
Local Institution, Toronto, Ontario, Canada
Local Institution, Montreal, Quebec, Canada
Local Institution, Odense, Denmark
Local Institution, Marseille, France
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu-hematology, Nantes, France
Local Institution, Pessac, France
Institut Claudius Regaud, Toulouse, France
Local Institution, Villejuif, France
Local Institution, Bergen, Norway
Local Institution, Oslo, Norway
Local Institution, Badalona, Spain
Local Institution, Barcelona, Spain
Local Institution, Madrid, Spain
Local Institution, Salamanca, Spain
Local Institution, Santander, Spain
Local Institution, Goteborg, Sweden
Local Institution, Huddinge, Sweden
Local Institution, Lund, Sweden
Local Institution, Edinburgh, United Kingdom
Local Institution, Oxford, United Kingdom
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT03591510
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Genova, GE, Italy
Novartis Investigative Site, Monza, MB, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Napoli, Italy
Childrens Hospital Colorado, Aurora, Colorado, United States
Miami Children s Hospital, Miami, Florida, United States
Novartis Investigative Site, Wien, Austria
Novartis Investigative Site, Brno, Czechia
Novartis Investigative Site, Praha 5, Czechia
Novartis Investigative Site, Regensburg, Bavaria, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Kobe-city, Hyogo, Japan
Novartis Investigative Site, Setagaya-ku, Tokyo, Japan
Novartis Investigative Site, Osaka, Japan
Novartis Investigative Site, Saitama, Japan
Novartis Investigative Site, Shizuoka, Japan
Novartis Investigative Site, Amman, Jordan
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Gdansk, Poland
Novartis Investigative Site, Krakow, Poland
Novartis Investigative Site, Ekaterinburg, Russian Federation
Novartis Investigative Site, Moscow, Russian Federation
Novartis Investigative Site, Ljubljana, Slovenia
Novartis Investigative Site, Adana, Turkey
Novartis Investigative Site, Antalya, Turkey
A Study to Assess the Efficacy and Safety of Entospletinib in Combination With Intensive Induction and Consolidation Chemotherapy in Adults With Newly Diagnosed Nucleophosmin 1-mutated Acute Myeloid Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT05020665
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
City of Hope, Duarte, California, United States
Indiana Blood & Marrow Transplantation, Indianapolis, Indiana, United States
University of Michigan Medical School, Ann Arbor, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Mount Sinai Health System, New York, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
Hollings Cancer Center, Charleston, South Carolina, United States
Bon Secours St. Francis Cancer Center, Greenville, South Carolina, United States
Juravinski Hospital, Hamilton, Canada
Universitätsklinikum Münster, Münster, Germany
Semmelweis Egyetem, Budapest, Hungary
Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary
Debreceni Egyetem Klinikai Központ, Debrecen, Hungary
Jósa András Oktatókórház, Nyíregyháza, Hungary
Szent-Györgyi Albert Klinikai Központ, Szeged, Hungary
Kyungpook National University Hospital, Daegu, Korea, Republic of
Daegu Catholic University Medical Center, Daegu, Korea, Republic of
Keimyung University Dongsan Hospital, Daegu, Korea, Republic of
Chungnam National University Hospital, Daejeon, Korea, Republic of
Seoul National University Hospital, Incheon, Korea, Republic of
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Severance Hospital, Seoul, Korea, Republic of
Uniwersyteckie Centrum Kliniczne w Gdańsku, Gdańsk, Poland
Samodzielny Publiczny Szpital Kliniczny Nr im. Prof. Tadeusza Sokołowskiego, Szczecin, Poland
Uniwersyteckie Centrum Kliniczne WUM - Centralny Szpital Kliniczny, Warsaw, Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Wrocław, Poland
Institut D'Investigacions Biomédiques August Pi I Sunyer, Barcelona, Spain
Hospital San Pedro de Alcantara, Cáceres, Spain
Hospital General Universitario Gregorio Marañón, Madrid, Spain
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Hospital Universitario Central de Asturias, Oviedo, Spain
Hospital Son Llàtzer, Palma De Mallorca, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain
Hospital Universitari I Politecnic La Fe, Valencia, Spain
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04174612
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, Bari, Italy
Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia, Bari, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
Aou Careggi- Sod Ematologia, Firenze, Italy
Asl Latina, Presidio Ospedaliero Nord - Ospedale Santa Maria Goretti - Uoc Ematologia, Latina, Italy
Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy
Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy
Ausl Della Romagna, Ospedale "Santa Maria Delle Croci" - Ravenna - Ematologia, Ravenna, Italy
Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia, Reggio Calabria, Italy
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia, Reggio Emilia, Italy
C.R.O.B. - I.R.C.C.S. - Rionero in Volture - Uoc Ematologia, Rionero In Vulture, Italy
Aou Policlinico Tor Vergata - Roma - Uoc Trapianto Cellule Staminali, Roma, Italy
Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy
Ospedale Mauriziano Umberto I - Torino - Scdu Ematologia, Torino, Italy
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04702425
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1
Novartis Investigative Site, Rozzano, MI, Italy
Novartis Investigative Site, Gent, Belgium
Novartis Investigative Site, HUS, Finland
Novartis Investigative Site, Heidelberg, Germany
Novartis Investigative Site, Hong Kong, Hong Kong
Novartis Investigative Site, Tel Aviv, Israel
Novartis Investigative Site, Sunto Gun, Shizuoka, Japan
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Santander, Cantabria, Spain
Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04460950
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
Ao Di Rilievo Nazionale E Di Alta Specialità "San Giuseppe Moscati" - Avellino - Uoc Ematologia Con Unità Di Trapianto, Avellino, Italy
Asl Caserta, Presidio Ospedaliero S.G.Moscati - Aversa - Uo Oncoematologia, Aversa, Italy
Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Asst Degli Spedali Civili Di Brescia - Ssvd Centro Trapianti Midollo Per Adulti - Cattedra Di Ematologia, Brescia, Italy
Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo, Cagliari, Italy
Aou Ospedali Riuniti - Foggia - Uoc Ematologia, Foggia, Italy
Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy
Ao Ospedali Riuniti "Papardo Piemonte" - Po Papardo - Messina - Sc Ematologia, Messina, Italy
Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora, Milano, Italy
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, Pagani, Italy
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy
Aou Di Parma - Sc Ematologia E Centro Trapianti Midollo Osseo, Parma, Italy
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
Aou Pisana - Uo Ematologia Universitaria, Pisa, Italy
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia, Reggio Emilia, Italy
Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia, Roma, Italy
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, Roma, Italy
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy
Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia, Sassari, Italy
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino, Torino, Italy
Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT03977103
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03503409
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
Ematologia ALESSANDRIA, Alessandria, Italy
CLINICA Ematologica ANCONA, Ancona, Italy
Ematologia BOLOGNA, Bologna, Italy
Ematologia BRESCIA, Brescia, Italy
Ematologia FIRENZE, Firenze, Italy
Clinica Ematologica Genova, Genova, Italy
Ematologia GENOVA, Genova, Italy
Ematologia LECCE, Lecce, Italy
Ematologia MILANO, Milano, Italy
Ematologia ORBASSANO, Orbassano, Italy
Ematologia ed Immunologia Clinica PADOVA, Padova, Italy
Reggio Calabria, Reggio Calabria, Italy
Ematologia ROMA, Roma, Italy
CH Angers, Angers, France
Centre Hospitalier de la Côte Basque, Bayonne, France
Hôpital Nord Franche-Comté/Service de médecine interne / Hématologie clinique, Belfort, France
CHU côte de Nacre, Caen, France
CHU de Grenoble/Clinique Universitaire d'hématologie 6e A, Grenoble, France
CH Le Mans/Service d'hématologie Oncologie, Le Mans, France
CHRU de Limoges, Limoges, France
centre hospitalier de Lyon, Lyon, France
Institut Paoli Calmettes/Unité d'Hématologie 3, Marseille, France
CHU Montpellier St Eloi, Montpellier, France
Hôpital E. Muller-GHR Mulhouse Sud-Alsace, Mulhouse, France
CHU Hôtel Dieu/Service d'Hématologie Clinique, Nantes, France
Hôpital Archet 1/Service d'Hématologie Clinique, Nice, France
GHU Caremeau, Nimes, France
Hôpital Saint Louis - Hématologie Séniors, Paris, France
Hôpital Necker, Paris, France
Hôpital Henri Mondor, Paris, France
CHU de Haut-Lévèque/Centre François Magendie/Service des maladies du sang, Pessac, France
CHU de Poitiers/Pôle de cancérologie - secteur tertiaire-, Poitiers, France
Centre Henri Becquerel, Rouen, France
institut de cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France
Médecine Interne/IUCT Oncopole, Toulouse, France
CHU de Tours, Tours, France
CHU Brabois, Vandœuvre-lès-Nancy, France
Centre Hospitalier de Versailles-Hôpital André Mignot, Versailles, France
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT03386513
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Instituto Europeo di Oncologia, Milano, Italy
Banner Health MD Anderson Cancer Center, Gilbert, Arizona, United States
City of Hope Medical Center, Duarte, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
Baylor Scott & White University Medical Center, Dallas, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, United States
Recherche Clinique-Hématologie, Amiens, France
CHU de Besancon, Hopital Jean Minjoz, Besançon, France
Hôpital St Antoine, Paris, France
Hospital Universitari I Politècnic La Fe, Valencia, Spain
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT04232241
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 2
ASST Papa Giovanni XXIII, Bergamo, Italy
LKH-Univ. Klinikum Graz, Graz, Austria
Medizinische Universität Innsbruck, Innsbruck, Austria
Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT, Wien, Austria
Institute of Hematology and Blood Transfusion, Prague, Czechia
Turku University Central Hospital, Turku, Finland
University Hospital Düsseldorf, Düsseldorf, Germany
Universitätsklinikum Essen, Essen, Germany
Universitätsklinikum Frankfurt am Main | Medizinische Klinik II, Frankfurt, Germany
Universitätsklinikum Freiburg, Freiburg, Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Medizinische Hochschule Hannover, Hannover, Germany
Universitätsklinikum Leipzig Dep. Innere Medizin, Neurologie und Dermatologie Medizinische Klinik und Poliklinik I - Hämatologie und Zelltherapie, Hämostaseologie, Leipzig, Germany
Universitätsklinikum Münster, Münster, Germany
Universitätsklinikum Tübingen, Tübingen, Germany
Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russian Federation
Hospital Universitari Germans Trias I Pujol, Badalona, Spain
Hospital Clínico y Provincial de Barcelona, Barcelona, Spain
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Hospital General Universitario Gregorio Marañón, Madrid, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Hospital Universitario Virgen del Rocío, Sevilla, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain
Hospital Universitario y Politécnico de La Fe, Valencia, Spain
CINC424A2X01B Rollover Protocol
- Stato: In arruolamento
- Fascia d'età: Bambini, AdultiAnziani
- Codice Sperimentazione: NCT02386800
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 4
Novartis Investigative Site, Ancona, AN, Italy
Novartis Investigative Site, Bari, BA, Italy
Novartis Investigative Site, Bologna, BO, Italy
Novartis Investigative Site, Brescia, BS, Italy
Novartis Investigative Site, San Giovanni Rotondo, FG, Italy
Novartis Investigative Site, Firenze, FI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Rozzano, MI, Italy
Novartis Investigative Site, Palermo, PA, Italy
Novartis Investigative Site, Palermo, PA, Italy
Novartis Investigative Site, Pavia, PV, Italy
Novartis Investigative Site, Reggio Calabria, RC, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Orbassano, TO, Italy
Novartis Investigative Site, Varese, VA, Italy
Novartis Investigative Site, Napoli, Italy
Novartis Investigative Site, Darlinghurst, New South Wales, Australia
Novartis Investigative Site, St Leonards, New South Wales, Australia
Novartis Investigative Site, Herston, Queensland, Australia
Novartis Investigative Site, Wooloongabba, Queensland, Australia
Novartis Investigative Site, Bedford Park, South Australia, Australia
Novartis Investigative Site, Box Hill, Victoria, Australia
Novartis Investigative Site, Clayton, Victoria, Australia
Novartis Investigative Site, Franston, Victoria, Australia
Novartis Investigative Site, Perth, Western Australia, Australia
Novartis Investigative Site, Antwerpen, Belgium
Novartis Investigative Site, Brugge, Belgium
Novartis Investigative Site, Leuven, Belgium
Novartis Investigative Site, Liege, Belgium
Novartis Investigative Site, Pleven, Bulgaria
Novartis Investigative Site, Plovdiv, Bulgaria
Novartis Investigative Site, Sofia, Bulgaria
Novartis Investigative Site, Sofia, Bulgaria
Novartis Investigative Site, Santiago, RM, Chile
Novartis Investigative Site, Vina del Mar, Valparaiso, Chile
Novartis Investigative Site, Santiago, Chile
Novartis Investigative Site, Beijing, Beijing, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Paris Cedex 10, France
Novartis Investigative Site, Aachen, Germany
Novartis Investigative Site, Dresden, Germany
Novartis Investigative Site, Dresden, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Magdeburg, Germany
Novartis Investigative Site, Mainz, Germany
Novartis Investigative Site, Ulm, Germany
Novartis Investigative Site, Athens, GR, Greece
Novartis Investigative Site, Patras, Greece
Novartis Investigative Site, Budapest, Hungary
Novartis Investigative Site, Debrecen, Hungary
Novartis Investigative Site, Kaposvar, Hungary
Novartis Investigative Site, Kecskemet, Hungary
Novartis Investigative Site, Szeged, Hungary
Novartis Investigative Site, Szombathely, Hungary
Novartis Investigative Site, Pune, Maharashtra, India
Novartis Investigative Site, Afula, Israel
Novartis Investigative Site, Jerusalem, Israel
Novartis Investigative Site, Nagoya, Aichi, Japan
Novartis Investigative Site, Fukuoka city, Fukuoka, Japan
Novartis Investigative Site, Isehara, Kanagawa, Japan
Novartis Investigative Site, Suita city, Osaka, Japan
Novartis Investigative Site, Bunkyo ku, Tokyo, Japan
Novartis Investigative Site, Osaka, Japan
Novartis Investigative Site, Seoul, Seocho Gu, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Republic of
Novartis Investigative Site, Beirut, Lebanon
Novartis Investigative Site, Monterrey, Nuevo Leon, Mexico
Novartis Investigative Site, Gliwice, Slaskie, Poland
Novartis Investigative Site, Wroclaw, Poland
Novartis Investigative Site, Lisboa, Portugal
Novartis Investigative Site, Lisboa, Portugal
Novartis Investigative Site, Moscow, Russian Federation
Novartis Investigative Site, Moscow, Russian Federation
Novartis Investigative Site, Petrozavodsk, Russian Federation
Novartis Investigative Site, Sain Petersburg, Russian Federation
Novartis Investigative Site, Bratislava, Slovakia
Novartis Investigative Site, Soweto, Gauteng, South Africa
Novartis Investigative Site, Cape Town, Western Province, South Africa
Novartis Investigative Site, Pretoria, South Africa
Novartis Investigative Site, Pretoria, South Africa
Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Pamplona, Navarra, Spain
Novartis Investigative Site, Huddinge, Sweden
Novartis Investigative Site, Lulea, Sweden
Novartis Investigative Site, Lund, Sweden
Novartis Investigative Site, Uddevalla, Sweden
Novartis Investigative Site, Bangkok, Bangkoknoi, Thailand
Novartis Investigative Site, Bangkok, Thailand
Novartis Investigative Site, Ankara, Sihhiye, Turkey
Novartis Investigative Site, Istanbul, Turkey
Novartis Investigative Site, Izmir, Turkey
Novartis Investigative Site, Talas / Kayseri, Turkey
A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT00600860
- Sesso: Tutti
- Tipologia Studio: Osservazionale
- Fase: Non disponibile
University of Pavia Medical SChool, Dept of Hematology, Pavia, Italy
University of Innsbruck Fachartz fur Innere Medizin, Dept of Hematology, Innsbruck, Austria
Clinical Hospital Merkur, Zagreb, Croatia
Institute of Haematology and Blood Transfusion U nemocnice, Prague, Czechia
Aarhus University Hospital, Aarhus, Denmark
Hopital Avicenne Universite Paris, Dept of Hematology, Paris, France
Medizinische Klinik und Poliklinik fur Haematologie, Onkologie und Klinische Immunologie, Dusseldorf, Germany
University of Patras Medical School, Haematology Division, Dept of Internal Medicine, Patras, Greece
Tel-Aviv Sourasky Medical Center, Dept. of Medicine A, Tel-Aviv, Israel
Radboud University Nijmegen Medical Centre, dept of Hematology, Nijmegen, Netherlands
Medical University, Dept of Hematology, Oncology and Internal Medicine, Warszawa, Poland
Instituto Português de Oncologia de Lisboa,, Lisbon, Portugal
Fundeni CLinical Institute, Clinic of Hematology, Bucharest, Romania
Clinical Center of Vojvodina, Novi Sad, Serbia
Hospital La Fe, Dept of Hematology, Valencia, Spain
Karolinsky Institute Huddinge University Hospital, Dept of Medicine Division HAematology, Stockholm, Sweden
Inselspital, Bern, Switzerland
Leeds General Infirmary Dept of Hematology, Leeds, United Kingdom
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias or Solid Tumors
- Stato: In arruolamento
- Fascia d'età:
- Codice Sperimentazione: NCT03934372
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
L AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S. ORSOLA � MALPIGHI, Bologna, Italy
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia, Italy
Ospedale Pediatrico G. Gaslini, Genova, Italy
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan, Italy
Ospedale San Gerardo - Asst Monza, Monza, Italy
University of Milano Bicocca, Monza, Italy
Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo, Pavia, Italy
Ospedale Pediatrico Bambino Gesu Irccs, Rome, Italy
Azienda Ospedaliero Universitaria Citta Della Salute E Della Scienza, Torino, Italy
Ghent University Hospital, Ghent, Belgium
The Finsen Centre National Hospital, Copenhagen, Denmark
Hopital Robert Debre, Paris, France
Armand Trousseau Hospital, Paris, France
Centre Hospitalier Universitaire de Poitiers, Poitiers, France
Chu de Rennes - Hospital Sud, Rennes, France
Universitaetsklinikum Erlangen - Medizinische Klinik 5, Erlangen, Germany
Universitatsklinikum Essen, Essen, Germany
Princess Maxima Center For Pediatric Oncology, Utrecht, Netherlands
Hospital Sant Joan de Deu de Manresa, Barcelona, Spain
Hospital Nino Jesus, Madrid, Spain
Hospital Universitario de La Paz, Madrid, Spain
Hospital Universitari I Politecnic La Fe, Valencia, Spain
Karolinska Universitetssjukhuset Solna, Solna, Sweden
Karolinska University Hospital Solna, Stockholm, Sweden
University Hospital Birmingham, Birmingham, United Kingdom
Royal Hospital For Sick Children Yorkhill Glasgow, Glasgow, United Kingdom
Alder Hey Childrens Nhs Foundation Trust, Liverpool, United Kingdom
The Royal Marsden Nhs Foundation Trust - Sutton, Sutton, United Kingdom
The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02688140
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 3
GIMEMA study group, Multiple Locations, Italy
French-Belgian-Swiss APL study group, Multiple Locations, France
AML-CG study group, Multiple Locations, Germany
AML-SG study group, Multiple Locations, Germany
OSHO study group, Multiple Locations, Germany
SAL study group, Multiple Locations, Germany
HOVON study group, Multiple Locations, Netherlands
PETHEMA study group, Multiple Locations, Spain
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies
- Stato: In arruolamento
- Fascia d'età: Adulti, Anziani
- Codice Sperimentazione: NCT02629692
- Sesso: Tutti
- Tipologia Studio: Interventistico
- Fase: Fase 1, Fase 2
Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Forli - Cesena, Italy
Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza, Milano, Italy
Azienda Ospedaliera Universitaria "Policlinico - Vittorio Emanuele" (Presidio Ferrarotto Alessi), Catania, Italy
Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, Italy
Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milano, Italy
Ospedale Sant'Eugenio, Roma, Italy
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Roma, Italy
The Oncology Institute of Hope and Innovation, Innovative Clinical Research Institute, Downey, California, United States
UCLA Hematologic Malignancy Program, Los Angeles, California, United States
University of Southern California, Los Angeles, California, United States
Mayo Clinic, Jacksonville, Florida, United States
Board of Regents of the University System of Georgia, Augusta, Georgia, United States
IU Simon Cancer Center, Indianapolis, Indiana, United States
Indiana Blood Marro Transplant, Indianapolis, Indiana, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Memorial Sloan Kettering Cancer Center - MAIN, New York, New York, United States
New York Medical College, Valhalla, New York, United States
East Carolina University, Greenville, North Carolina, United States
Baylor University Medical Center, Dallas, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute University of Utah, Salt Lake City, Utah, United States
ZNA Stuivenberg, Antwerpen, Belgium
Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
UZ Leuven, Leuven, Belgium
Institut Paoli Calmettes, Marseille Cedex 9, Bouches-du-Rhône, France
Institut Bergonié, Bordeaux cedex, Gironde, France
CHU de Limoges - Hôpital Dupuytren, Limoges cedex, Haute Vienne, France
CHU Rennes - Hopital Pontchaillou, Rennes cedex 9, Ille Et Vilaine, France
CHU de Nantes - Hotel Dieu, Nantes cedex 1, Loire Atlantique, France
CHU Angers - Hôpital Hôtel Dieu, Angers, Maine Et Loire, France
CHU de Nancy - Hôpital de Brabois Adultes, Vandœuvre-lès-Nancy, Meurthe Et Moselle, France
Hopital Claude Huriez - CHRU Lille, Lille cedex, Nord, France
Hôpital Saint-Louis, Paris cedex 10, Paris, France
Centre Léon Bérard, Lyon Cedex 08, Rhone, France
Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhone, France
Hôpital Avicenne, Bobigny cedex, Seine Saint Denis, France
CHU Amiens - Hopital Sud, Salouel, Somme, France
CHU Poitiers - Hôpital la Milétrie, Poitiers, Vienne, France
Semmelweis Egyetem, Budapest, Hungary
Debreceni Egyetem, Debrecen, Hungary
SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz, Nyiregyhaza, Hungary
Pecsi Tudomanyegyetem, Pecs, Hungary
Prince Aly Khan Hospital, Mumbai, Maharashtra, India
Tata Memorial Hospital, Mumbai, Maharashtra, India
Sahyadri Specialty Hospital, Pune, Maharashtra, India
Meenakshi Mission Hospital & Research Centre, Madurai, Tamilnadu, India
Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
Tata Medical Centre, Kolkata, West Bengal, India
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Gyeonggi-do, Korea, Republic of
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Gyeonggi-do, Korea, Republic of
Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi-do, Korea, Republic of
Spitalul Clinic Colentina, Bucuresti, Romania
Spitalul Clinic Coltea, Bucuresti, Romania
Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania
Spitalul Clinic Municipal Filantropia Craiova, Craiova, Romania
Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureș, Romania
Singapore General Hospital, Singapore, Singapore
ICO Badalona - Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital Universitari Vall d'Hebron, Barcelona, Spain
ICO Girona - Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Clinico Universitario Virgen de la Victoria, Málaga, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Hospital Universitario Virgen Macarena, Sevilla, Spain
Hospital Universitario Virgen del Rocio, Sevilla, Spain
King's College Hospital, London, Greater London, United Kingdom
Hammersmith Hospital, London, Greater London, United Kingdom